Evidence map›Paper›PMID 36647231›Full record

ArticleJournal of clinical neurology (Seoul, Korea)2023

Risk of Cognitive Impairment in Patients With Parkinson's Disease With Visual Hallucinations and Subjective Cognitive Complaints.

Diego Santos-García, Teresa de Deus Fonticoba, Carlos Cores Bartolomé, Maria J Feal Painceiras, Jose M Paz González, Cristina Martínez Miró, Silvia Jesús, Miquel Aguilar, Pau Pastor, Lluís Planellas and 40 more

Open access · diamondAbstract read
In one paragraph

Article in Journal of clinical neurology (Seoul, Korea), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Subjective cognitive complaints in cognitively unimpaired Parkinson's disease: Associations with affective burden, motor severity, and awareness-related processes.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  2. Parkinson's disease-subjective cognitive decline and health-related quality of life.Journal of neural transmission (Vienna, Austria : 1996) · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

50 authors at 20 institutions in 2 countries.

Diego Santos-GarcíaCHUAC, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain. diegosangar@yahoo.es.ORCID https://orcid.org/0000-0002-3126-5111
Teresa de Deus FonticobaCHUF, Complejo Hospitalario Universitario de Ferrol, A Coruña, Spain.
Carlos Cores BartoloméCHUAC, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain.
Maria J Feal PainceirasCHUAC, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain.
Jose M Paz GonzálezCHUAC, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain.
Cristina Martínez MiróCHUAC, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain.
Silvia JesúsUnidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain.
Miquel AguilarHospital Universitari Mutua de Terrassa, Terrassa, Spain.
Pau PastorHospital Universitari Mutua de Terrassa, Terrassa, Spain.
Lluís PlanellasClínica del Pilar, Barcelona, Spain.
Marina CosgayaHospital Clínic de Barcelona, Barcelona, Spain.
Juan García CaldenteyCentro Neurológico Oms 42, Palma de Mallorca, Spain.
Nuria CaballolConsorci Sanitari Integral, Hospital Moisés Broggi, Sant Joan Despí, Spain.
Ines LegardaHospital Universitario Son Espases, Palma de Mallorca, Spain.
Jorge Hernández VaraCIBERNED (Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas), Madrid, Spain.
Iria CaboComplejo Hospitalario Universitario de Pontevedra (CHOP), Pontevedra, Spain.
Lydia López ManzanaresHospital Universitario La Princesa, Madrid, Spain.
Isabel González AramburuCIBERNED (Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas), Madrid, Spain.
Maria A Ávila RiveraConsorci Sanitari Integral, Hospital General de L'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain.
Víctor Gómez MayordomoHospital Universitario Clínico San Carlos, Madrid, Spain.
Víctor NogueiraHospital Da Costa, Burela, Lugo, Spain.
Víctor PuenteHospital del Mar, Barcelona, Spain.
Julio Dotor García-SotoHospital Universitario Virgen Macarena, Sevilla, Spain.
Carmen BorruéHospital Infanta Sofía, Madrid, Spain.
Berta Solano VilaInstitut d'Assistència Sanitària (IAS)-Institut Català de la Salut, Girona, Spain.
María Álvarez SaucoHospital General Universitario de Elche, Elche, Spain.
Lydia VelaFundación Hospital de Alcorcón, Madrid, Spain.
Sonia EscalanteHospital de Tortosa Verge de la Cinta (HTVC), Tortosa, Spain.
Esther CuboComplejo Asistencial Universitario de Burgos, Burgos, Spain.
Francisco Carrillo PadillaHospital Universitario de Canarias, San Cristóbal de la Laguna, Spain.
Juan C Martínez CastrilloHospital Universitario Ramón y Cajal, RYCIS, Madrid, Spain.
Pilar Sánchez AlonsoHospital Universitario Puerta de Hierro, Madrid, Spain.
Maria G Alonso LosadaHospital Álvaro Cunqueiro, Complejo Hospitalario Universitario de Vigo (CHUVI), Vigo, Spain.
Nuria López ArizteguiComplejo Hospitalario de Toledo, Toledo, Spain.
Itziar GastónComplejo Hospitalario de Navarra, Pamplona, Spain.
Jaime KulisevskyCIBERNED (Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas), Madrid, Spain.
Marta Blázquez EstradaHospital Universitario Central de Asturias, Oviedo, Spain.
Manuel SeijoComplejo Hospitalario Universitario de Pontevedra (CHOP), Pontevedra, Spain.
Javier Rúiz MartínezHospital Universitario Donostia, San Sebastián, Spain.
Caridad ValeroHospital Arnau de Vilanova, Valencia, Spain.
Mónica KurtisHospital Ruber Internacional, Madrid, Spain.
Oriol de FábreguesHospital Universitario Vall d'Hebron, Barcelona, Spain.
Jessica González ArduraHospital de Cabueñes, Gijón, Spain.
Ruben Alonso RedondoUniversitario Lucus Augusti (HULA), Lugo, Spain.
Carlos OrdásHospital Rey Juan Carlos, Madrid, Spain.
Luis M López Díaz LComplejo Hospitalario Universitario de Orense (CHUO), Orense, Spain.
Darrian McAfeeUniversity of Maryland School of Medicine, Baltimore, MD, USA.
Pablo Martinez-MartinCIBERNED (Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas), Madrid, Spain.
Pablo MirUnidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain.
COPPADIS Study Group
Complexo Hospitalario Universitario A Coruña · ESBiomedical Research Networking Center on Neurodegenerative Diseases · ESComplejo Hospitalario de Pontevedra · ESMútua Terrassa · ESAjuntament de L’Hospitalet · ESBiogipuzkoa Health Research Institute · ESComplejo Hospitalario de Navarra · ESComplejo Hospitalario de Ourense · ESComplejo Hospitalario Universitario de Toledo · ESHospital Arnau de Vilanova · ESHospital Clínic de Barcelona · ESHospital Clínico San Carlos · ESHospital Costa del Sol · ESHospital Del Mar · ESHospital de Sant Joan Despí Moisès Broggi · ESHospital de Sant Pau · ESHospital General Universitario de Elche · ESHospital Ruber Internacional · ESHospital Universitari de Tortosa Verge de la Cinta · ESHospital Universitario Central de Asturias · ES

Funding

Instituto de Salud Carlos IIIMinisterio de Economía y Competitividad PI16/01575
6 · The paper itself

Abstract

background and purposeVisual hallucinations (VH) and subjective cognitive complaints (SCC) are associated with cognitive impairment (CI) in Parkinson's disease. Our aims were to determine the association between VH and SCC and the risk of CI development in a cohort of patients with Parkinson's disease and normal cognition (PD-NC).

methodsPatients with PD-NC (total score of >80 on the Parkinson's Disease Cognitive Rating Scale [PD-CRS]) recruited from the Spanish COPPADIS cohort from January 2016 to November 2017 were followed up after 2 years. Subjects with a score of ≥1 on domain 5 and item 13 of the Non-Motor Symptoms Scale at baseline (V0) were considered as "with SCC" and "with VH," respectively. CI at the 2-year follow-up (plus or minus 1 month) (V2) was defined as a PD-CRS total score of <81.

resultsAt V0 (

conclusionsVH were associated with the development of SCC and CI at the 2-year follow-up in patients with PD-NC.

Indexed as

cognitive impairmentdementiaparkinson's diseasesubjective cognitive complaintsvisual hallucinations

Identifiers

PMID36647231
PMCPMC10329922
OpenAlexW4316928494

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.